Valentine 2014.
Methods | RCT |
Participants | 90 pregnant women (19‐20 weeks GA); > 18 years; diagnosed with hypertension; without bleeding disorders, lupus, autoimmune diseases, or presence of infant congenital (trisomy 13, 18, 21, urethral, gastrointestinal and cardiac defects) |
Interventions | 1) 200 mg DHA daily, from 18‐20 weeks GA to 6 weeks postpartum 2) 1000 mg DHA daily, from 18‐20 weeks GA to 6 weeks postpartum |
Outcomes | Primary: endothelial health (measures not reported); secondary: maternal homoeostasis (blood and cord blood concentrations of pro‐inflammatory cytokines IL‐6, I L‐8, TNF a, and receptor sRAGE |
Notes | May have been withdrawn/never commenced |